These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 14717608

  • 1. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE, Cai F, Neale EA.
    Biochemistry; 2004 Jan 20; 43(2):526-32. PubMed ID: 14717608
    [Abstract] [Full Text] [Related]

  • 2. Syntaxin and 25-kDa synaptosomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival.
    Williamson LC, Neale EA.
    J Neurosci Res; 1998 Jun 01; 52(5):569-83. PubMed ID: 9632313
    [Abstract] [Full Text] [Related]

  • 3. Persistence of botulinum neurotoxin action in cultured spinal cord cells.
    Keller JE, Neale EA, Oyler G, Adler M.
    FEBS Lett; 1999 Jul 30; 456(1):137-42. PubMed ID: 10452545
    [Abstract] [Full Text] [Related]

  • 4. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
    Keller JE, Neale EA.
    J Biol Chem; 2001 Apr 20; 276(16):13476-82. PubMed ID: 11278807
    [Abstract] [Full Text] [Related]

  • 5. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
    Lawrence GW, Foran P, Mohammed N, DasGupta BR, Dolly JO.
    Biochemistry; 1997 Mar 18; 36(11):3061-7. PubMed ID: 9115981
    [Abstract] [Full Text] [Related]

  • 6. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F, Humeau Y, Vitiello F, Popoff MR, Poulain B.
    J Soc Biol; 1999 Mar 18; 193(6):457-67. PubMed ID: 10783704
    [Abstract] [Full Text] [Related]

  • 7. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV, Yoshino K, Jahnz M, Dörries C, Bade S, Nauenburg S, Niemann H, Binz T.
    J Neurochem; 1999 Jan 18; 72(1):327-37. PubMed ID: 9886085
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK, Singh BR.
    Biochemistry; 2004 Apr 27; 43(16):4791-8. PubMed ID: 15096048
    [Abstract] [Full Text] [Related]

  • 9. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
    Lawrence GW, Wang J, Brin MF, Aoki KR, Wheeler L, Dolly JO.
    FEBS J; 2014 Jul 27; 281(14):3243-60. PubMed ID: 24863955
    [Abstract] [Full Text] [Related]

  • 10. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyze the SNAP-23 present.
    Chen F, Foran P, Shone CC, Foster KA, Melling J, Dolly JO.
    Biochemistry; 1997 May 13; 36(19):5719-28. PubMed ID: 9153412
    [Abstract] [Full Text] [Related]

  • 11. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa.
    Williamson LC, Halpern JL, Montecucco C, Brown JE, Neale EA.
    J Biol Chem; 1996 Mar 29; 271(13):7694-9. PubMed ID: 8631808
    [Abstract] [Full Text] [Related]

  • 12. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
    Lawrence GW, Foran P, Dolly JO.
    Eur J Biochem; 1996 Mar 15; 236(3):877-86. PubMed ID: 8665909
    [Abstract] [Full Text] [Related]

  • 13. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
    Raciborska DA, Trimble WS, Charlton MP.
    Eur J Neurosci; 1998 Aug 15; 10(8):2617-28. PubMed ID: 9767392
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
    Lawrence GW, Ovsepian SV, Wang J, Aoki KR, Dolly JO.
    Neuropharmacology; 2013 Jul 15; 70():287-95. PubMed ID: 23485402
    [Abstract] [Full Text] [Related]

  • 15. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Südhof TC, Niemann H, Jahn R.
    Nature; 1993 Sep 09; 365(6442):160-3. PubMed ID: 8103915
    [Abstract] [Full Text] [Related]

  • 16. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
    Restani L, Giribaldi F, Manich M, Bercsenyi K, Menendez G, Rossetto O, Caleo M, Schiavo G.
    PLoS Pathog; 2012 Dec 09; 8(12):e1003087. PubMed ID: 23300443
    [Abstract] [Full Text] [Related]

  • 17. Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.
    Purkiss JR, Friis LM, Doward S, Quinn CP.
    Neurotoxicology; 2001 Aug 09; 22(4):447-53. PubMed ID: 11577803
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
    Apland JP, Adler M, Oyler GA.
    J Protein Chem; 2003 Feb 09; 22(2):147-53. PubMed ID: 12760419
    [Abstract] [Full Text] [Related]

  • 19. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
    Pellett S, Tepp WH, Scherf JM, Johnson EA.
    PLoS One; 2015 Feb 09; 10(7):e0133737. PubMed ID: 26207366
    [Abstract] [Full Text] [Related]

  • 20. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.